
Aqua Pharmaceuticals
Stage
Acquired | AcquiredValuation
$0000About Aqua Pharmaceuticals
Aqua Pharmaceuticals is an independent, privately owned specialty pharmaceutical company. Dedicated to helping patients achieve their goals of healthy skin and a positive self-image, Aqua acquires, develops and markets drugs indicated for the treatment of dermatological conditions. The company has branded prescription drugs in four therapeutic categories that include acne, steroid-responsive dermatoses, actinic keratoses and seborrheic dermatitis. These products have earned acceptance by both dermatologists and patients due to their clinical effectiveness, high quality and cosmetic elegance.
Loading...
Loading...
Aqua Pharmaceuticals Patents
Aqua Pharmaceuticals has filed 1 patent.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
1/26/2006 | 8/6/2013 | Trombidiformes, Cutaneous conditions, Rare diseases, Inflammations, Dermal and subcutaneous growths | Grant |
Application Date | 1/26/2006 |
---|---|
Grant Date | 8/6/2013 |
Title | |
Related Topics | Trombidiformes, Cutaneous conditions, Rare diseases, Inflammations, Dermal and subcutaneous growths |
Status | Grant |
Latest Aqua Pharmaceuticals News
Jul 25, 2021
Actinic keratosis is a chronic and prevalent disease affecting areas of sun-exposed skin where visible and subclinical, non-visible lesions coexist. This area of sun-damaged skin is prone to the development of further visible Actinic Keratosis lesions and sun-related skin cancer and is known as ‘field cancerization’. Actinic Keratosis lesions are being represented as small scaly patches that can be flat or slightly raised. Their color can range from one's skin tone to a reddish-brown color. They differ in size from 3 mm to 10 mm across, and they may gradually enlarge. Actinic Keratosis lesions appear on areas which are most commonly exposed to sun, such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc. DelveInsight's " Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Actinic Keratosis , historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Actinic Keratosis is more prevalent among male than female population. DelveInsight estimates that the male-to-female ratios of Actinic Keratosis patients differ among various countries, but a male excess is a consistent finding among all countries except Italy. As per the estimation by DelveInsight’s analysts, the United States had the highest prevalence of Actinic Keratosis with approximately 66 million prevalent population in 2020. Among the EU5 countries, Germany had the highest prevalent population with approximately 8 million cases followed by the United Kingdom with prevalent population of approximately 5 million in 2020. On the other hand, Japan has the lowest prevalent population with approximately 7 lakh Actinic keratosis cases in 2020. Our analysis also suggests that due to the high prevalence of Actinic Keratosis and potential for lesions to become cancerous, maximum patients are treated. Rough, dry or scaly patch of skin, usually less than 1 inch (2.5 centimeters) in diameter Flat to slightly raised patch or bump on the top layer of skin In some cases, a hard, wartlike surface Color variations, including pink, red or brown Itching, burning, bleeding or crusting New patches or bumps on sun-exposed areas of the head, neck, hands and forearms Sandoz Pharmaceuticals LEO Pharma Competitive Intelligence Analysis for Actinic Keratosis Actinic Keratosis : Market Overview at a Glance Actinic Keratosis : Disease Background and Overview Patient Journey Treatment Algorithm, Current Treatment, and Medical Practices Unmet Needs Marketed Products Attribute analysis KOL Views
Aqua Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Aqua Pharmaceuticals's headquarters?
Aqua Pharmaceuticals's headquarters is located at 158 West Gay Street, West Chester.
What is Aqua Pharmaceuticals's latest funding round?
Aqua Pharmaceuticals's latest funding round is Acquired.
Who are the investors of Aqua Pharmaceuticals?
Investors of Aqua Pharmaceuticals include Almirall and RoundTable Healthcare Partners.
Loading...
Loading...